Bumetanide and Hyperbilirubinaemia aggravated - a phase IV clinical study of FDA data

Summary:

Hyperbilirubinaemia aggravated is reported as a side effect among people who take Bumetanide (bumetanide), especially for people who are female, 60+ old, also take Lasix, and have Gout.

The phase IV clinical study analyzes which people have Hyperbilirubinaemia aggravated when taking Bumetanide. It is created by eHealthMe based on reports of 20,353 people who have side effects when taking Bumetanide from the FDA, and is updated regularly.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

What is Hyperbilirubinaemia aggravated?

Hyperbilirubinaemia aggravated (excess of bilirubin in the blood) is found to be associated with 811 drugs and 377 conditions by eHealthMe. Check the latest studies of Hyperbilirubinaemia aggravated.

On Jul, 10, 2026

20,353 people reported to have side effects when taking Bumetanide.
Among them, 22 people (0.11%) have Hyperbilirubinaemia aggravated.

Could Bumetanide cause Hyperbilirubinaemia aggravated?

Among these 22 people:

What is the gender of people who have Hyperbilirubinaemia aggravated when taking Bumetanide? *

female: 80 %
male: 20 %

What is the age of people who have Hyperbilirubinaemia aggravated when taking Bumetanide? *

What are other drugs people take besides Bumetanide? *

What are other side effects people have besides Hyperbilirubinaemia aggravated? *

Abdominal Distension: 5 people, 22.73%
Face Oedema (swelling of face): 5 people, 22.73%
Thrombocytopenia (decrease of platelets in blood): 5 people, 22.73%
Ascites (accumulation of fluid in the abdominal cavity): 4 people, 18.18%
Haemoglobin Decreased: 4 people, 18.18%
Renal Impairment (severely reduced kidney function): 4 people, 18.18%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 18.18%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 18.18%
Diarrhea: 4 people, 18.18%
Rashes (redness): 4 people, 18.18%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 18.18%
Gout (uric acid crystals building up in the body): 4 people, 18.18%
Staphylococcal Bacteraemia (a bacterial infection of blood): 2 people, 9.09%
Endocarditis Staphylococcal (an inflammation of the inner layer of the heart by staphylococcal bacterial infection): 2 people, 9.09%
Type 2 Diabetes: 1 person, 4.55%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 4.55%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 4.55%
Multiple Myeloma (cancer of the plasma cells): 1 person, 4.55%
Migraine (headache): 1 person, 4.55%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and have Hyperbilirubinaemia aggravated?

- Check whether Hyperbilirubinaemia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bumetanide:

Bumetanide (20,532 reports)

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperbilirubinaemia aggravated:

Hyperbilirubinaemia aggravated (811 drugs)

Browse all the conditions that are associated with Hyperbilirubinaemia aggravated:

Hyperbilirubinaemia aggravated (377 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bumetanide (the active ingredients of Bumetanide) and Bumetanide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.